Polimorfismo clínico de linfogranuloma venéreo anorrectal en la Ciudad de Buenos Aires / Clinical polymorphism of anorectal lymphogranuloma venereum in Buenos Aires City

Desde 2003, en los países desarrollados han aumentado las comunicaciones sobre casos de linfogranuloma venéreo con cuadros clínicos diferentes de la forma inguinal clásica. Las presentaciones anorrectales, hasta hace poco atípicas, predominan en hombres infectados por HIV que tienen sexo con hombres. El objetivo de este trabajo es informar sobre la presencia de esta infección en la Ciudad Autónoma de Buenos Aires y describir sus variadas manifestaciones clínicas. En el contexto de una pesquisa sistemática de la infección rectal por clamidias, en apenas un trimestre fueron identificados ocho casos de linfogranuloma venéreo por Chlamydia trachomatis biovar LGV en hombres HIV positivos que tienen sexo con hombres. Las manifestaciones anorrectales más frecuentes fueron pujo, tenesmo, urgencia evacuatoria y secreción mucosa o hemopurulenta. En su mayoría presentaban proctitis leve o moderada, acompañada en algunos casos de lesiones perianales. Dados el polimorfismo y la inespecificidad de las manifestaciones clínicas del linfogranuloma venéreo rectal, se advierte sobre la circulación de esta infección en nuestro medio. En caso de detectar Chlamydia trachomatis, es importante genotipificarla para el correcto diagnóstico y tratamiento de la enfermedad y también para su vigilancia epidemiológica. Si la genotipificación no es posible, se debe considerar el caso como producido por el biovar LGV y aplicar el tratamiento correspondiente.

From 2003 to date there has been a rising number of reports from developed countries on cases of lymphogranuloma venereum with anorectal localization in HIV-infected men who have sex with men. This localization differs from the classical inguinal abscesses which are typical of the disease in the tropics. The objective of this work is to document the presence of anorectal lymphogranuloma venereum in Buenos Aires and to describe its varied clinical manifestations. In the context of a systematic survey of rectal chlamydial infection, in just one trimester, eight cases of lymphogranuloma venereum caused by Chlamydia trachomatis biovar LGV were identified in HIV-infected men who have sex with men. The most frequent anorectal manifestations were pus, tenesmus, rectal urgency, and mucous or haemopurulent discharge. The proctitis was mostly mild or moderate and, in some cases, it was accompanied by perianal lesions. Given the great polymorphism and unspecificity of the clinical manifestations of the disease, we warn on the presence of this form of rectal lymphogranuloma venereum in our setting. If Chlamydia trachomatis is detected, it should be genotyped, not only for the correct diagnosis and treatment but also for epidemiological surveillance. Where genotyping is not available, the disease must be considered as caused by the LGV biovar and treated accordingly.

The role of a commercial enzyme immuno assay antigen detection system for diagnosis of C. trachomatis in genital swab samples.

In the present pilot study, endocervical and urethral swabs collected from 100 patients attending sexually transmitted disease (STD) clinics and regional centre for STD in two referral hospitals in New Delhi were analyzed by enzyme immune assay (EIA), polymerase chain reaction (PCR) and direct fluorescent antibody (DFA) for detection of C. trachomatis. It was found that EIA could detect a very low number of cases (3/100) as against DFA (11/100) and PCR (9/100). Thus, in spite of the widespread availability, lower cost and ease of performance of the enzyme-linked-immunosorbent serologic assay, the present study highlights the need to employ sophisticated diagnostic tools like DFA and PCR for detection of Chlamydia trachomatis in STD patients.